Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950170-25-037933
Filing Date
2025-03-12
Accepted
2025-03-12 16:11:17
Documents
84
Period of Report
2024-12-31

Document Format Files

Seq Description Document Type Size
1 10-K allk-20241231.htm   iXBRL 10-K 2712101
2 EX-4.2 allk-ex4_2.htm EX-4.2 47548
3 EX-10.11D allk-ex10_11d.htm EX-10.11D 85806
4 EX-19.1 allk-ex19_1.htm EX-19.1 252714
5 EX-23.1 allk-ex23_1.htm EX-23.1 5641
6 EX-31.1 allk-ex31_1.htm EX-31.1 18097
7 EX-31.2 allk-ex31_2.htm EX-31.2 18113
8 EX-32.1 allk-ex32_1.htm EX-32.1 9863
9 EX-32.2 allk-ex32_2.htm EX-32.2 9874
10 GRAPHIC img3577613_0.jpg GRAPHIC 34125
11 GRAPHIC img3577613_1.jpg GRAPHIC 34125
12 GRAPHIC img3577613_2.jpg GRAPHIC 34125
  Complete submission text file 0000950170-25-037933.txt   10991262

Data Files

Seq Description Document Type Size
13 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT allk-20241231.xsd EX-101.SCH 1375735
87 EXTRACTED XBRL INSTANCE DOCUMENT allk-20241231_htm.xml XML 1804893
Mailing Address 825 INDUSTRIAL ROAD SUITE 500 SAN CARLOS CA 94070
Business Address 825 INDUSTRIAL ROAD SUITE 500 SAN CARLOS CA 94070 650-597-5002
Allakos Inc. (Filer) CIK: 0001564824 (see all company filings)

EIN.: 454798831 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-38582 | Film No.: 25731840
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)